Entry Detail



General Information

Database ID:exR0373243
RNA Name:NUTM2A-AS1
RNA Type:lncRNA
Chromosome:chr10
Starnd:-
Coordinate:
Start Site(bp):87201647End Site(bp):87342612
External Links:ENSG00000223482



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:NA
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-148b-3p
chr12
54337278
54337299
+
hsa-let-7a-5p
chr9
94175962
94175983
+
hsa-miR-4428
chr1
237471164
237471185
+
hsa-miR-4458
chr5
8460933
8460951
+
hsa-miR-107
chr10
89592756
89592778
-
hsa-miR-129-5p
chr7
128207876
128207896
+
hsa-let-7c-5p
chr21
16539838
16539859
+
hsa-miR-15a-5p
chr13
50049167
50049188
-
hsa-miR-376a-3p
chr14
101040825
101040845
+
hsa-miR-424-5p
chrX
134546680
134546701
-
hsa-miR-16-5p
chr3
160404754
160404775
+
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-139-5p
chr11
72615102
72615124
-
hsa-let-7d-5p
chr9
94178841
94178862
+
hsa-let-7b-5p
chr22
46113691
46113712
+
hsa-miR-488-3p
chr1
177029374
177029394
-
hsa-miR-148a-3p
chr7
25949922
25949943
-
hsa-let-7e-5p
chr19
51692793
51692814
+
hsa-miR-942-5p
chr1
117094655
117094676
+
hsa-let-7i-5p
chr12
62603691
62603712
+
hsa-miR-4524a-5p
chr17
69099606
69099627
-
hsa-miR-6884-5p
chr17
40026383
40026404
-
hsa-miR-4524b-5p
chr17
69099570
69099590
+
hsa-miR-548o-3p
chr20
38516607
38516628
+
hsa-miR-4500
chr13
87618671
87618687
-
hsa-miR-409-5p
chr14
101065314
101065336
+
hsa-miR-485-5p
chr14
101055427
101055448
+
hsa-miR-6838-5p
chr7
44073407
44073428
-
hsa-miR-195-5p
chr17
7017667
7017687
-
hsa-miR-15b-5p
chr3
160404607
160404628
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL132656.3
chr10
79663192
79664786
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:945
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.